An experimental drug shrank tumors in patients with a variety of cancers sharing the same genetic defect, new studies found, part of a push in oncology research to treat tumors by their molecular traits regardless of where they are in the body. Read Full Story
The post The Wall Street Journal: Drug targeting genetic defect shared by different cancers succeeds in shrinking tumors appeared first on ForexTV.
June 03, 2017 at 09:33PM
from Market Watch
No comments:
Post a Comment